Vice President, Clinical Science and Operations jobs in United States
cer-icon
Apply on Employer Site
company-logo

Geron Corporation · 1 day ago

Vice President, Clinical Science and Operations

Geron Corporation is seeking a Vice President of Clinical Science and Operations to lead the strategic direction of clinical development programs. This senior leadership role involves overseeing clinical trials, ensuring alignment with corporate goals, and mentoring teams to optimize clinical operations and data generation.

BiopharmaBiotechnologyHealth DiagnosticsOncologyPharmaceutical
check
Diversity & Inclusion

Responsibilities

Lead and integrate the scientific and operational strategies for clinical development programs, spanning early development and Phases I–IV and post-marketing studies, to support regulatory submissions, commercialization, and lifecycle management
Collaborate with executive leadership and cross-functional partners to align clinical development plans with corporate objectives and commercial priorities as part of RDLT
Provide guidance to the Chief Medical Officer, Head of R&D, and senior leaders on clinical trial design, data interpretation, risk management, and scientific rigor
Direct the development and oversight of clinical protocols, study designs, and scientific plans as a member of the early- and late-stage PDTs
Oversee planning, initiation, and execution of clinical trials, ensuring delivery on time and with high quality
Oversee feasibility assessments and select trial geographies to ensure strategic fit and operational efficiency
Drive site/investigator selection, engagement, and relationship management to optimize enrollment and site performance
Oversee contract research organization (CRO) and vendor management, ensuring compliance, performance, and issue resolution
Manage clinical program budgets, track spending, and align resources with portfolio priorities
Oversee and support post-marketing trials and real-world evidence generation initiatives on safety, efficacy, and market value
Support collection, analysis, and reporting of clinical and post-marketing data to ensure accurate safety monitoring and continuous product profile optimization
Engage and collaborate with key opinion leaders, healthcare professionals, vendors, and CROs to enhance study execution, scientific validity, and product adoption
Lead, mentor, and develop high-performing Clinical Science and Clinical Operations teams, fostering a culture of innovation, accountability, and continuous professional growth
Ensure Clinical Science and Clinical Operations deliverables meet timelines, budget, quality, and compliance standards
Ensure clinical trials comply with ICH-GCP, global regulatory guidelines, and internal SOPs
Drive proactive identification and resolution of clinical and operational issues and lead process improvement initiatives
Represent the Clinical Science and Clinical Operations departments in internal leadership forums, external presentations, and cross-functional governance bodies
Collaborate on the preparation of regulatory submissions, including post-marketing commitments, safety updates, and payer evidence packages as part of RDLT
Lead and contribute to process improvement initiatives, development of department SOPs, and clinical development plans

Qualification

Clinical drug developmentTrial executionRegulatory complianceLeadership skillsPost-marketing studiesBudget managementClinical methodologyCross-functional collaborationAnalytical skillsCommunication skillsInterpersonal skillsOrganizational skillsProblem-solving skills

Required

Advanced degree (MD, PhD or PharmD preferred) in medicine, pharmacology, biology, or a related field strongly preferred; Bachelor's degree in a scientific discipline plus extensive clinical experience will also be considered
Minimum of 15 years of experience in clinical development, including leadership roles
Proven track record of success in leading clinical programs through regulatory approval, commercialization, and post-marketing phases
Experience building and leading cross-functional teams
Previous experience with pre-clinical and Phase I - IV studies
Previous experience managing CROs/vendors
In-depth knowledge of clinical drug development, trial execution, study management, and monitoring procedures
Strong understanding of IND enabling activities and studies
Strong understanding of trial design, clinical methodology, and study protocols across phases and indications
Expertise in post-marketing studies, real-world evidence generation, and lifecycle management
Well-versed in GCP, ICH guidelines, and global regulatory requirements (FDA, EMA, etc.)
Strong analytical skills with the ability to translate complex data into actionable insights
Strategic mindset with proven ability to balance long-term planning and day-to-day execution
Financial acumen with ability to assess and manage budget scope changes
Proven leadership and team-building skills with a focus on results and accountability
Ability to lead and collaborate across cross-functional teams, including CROs and external vendors
Ability to motivate teams to meet deadlines and project goals with minimal oversight
Excellent verbal and written communication skills
Polished presenter with the ability to engage internal and external stakeholders effectively
Strong interpersonal skills with a professional, service-oriented mindset
Highly organized, self-motivated, and capable of independent decision-making
Strong ability to resolve project issues and prioritize competing demands
Committed to continuous improvement and process optimization

Benefits

Medical
Dental
Vision
Life insurance
Flexible spending accounts
Disability insurance
Supplemental health insurance
401(k) retirement savings plan
Employee stock purchase plan
160 hours of vacation during each full year of employment
64 hours of sick leave
9 standard paid holiday days off
Paid leave for certain life events

Company

Geron Corporation

twittertwitter
company-logo
Geron is a biopharmaceutical company that is charting a new course with the goal to deliver innovative treatment options for people living with blood cancer.

Funding

Current Stage
Public Company
Total Funding
$999.54M
Key Investors
Pharmakon Advisors
2024-11-07Post Ipo Debt· $250M
2024-03-19Post Ipo Equity· $150M
2023-01-05Post Ipo Equity· $227.84M

Leadership Team

leader-logo
Harout Semerjian
President & CEO
linkedin
leader-logo
Michelle Robertson
Chief Financial Officer
linkedin
Company data provided by crunchbase